Piceatannol attenuates lipopolysaccharide-induced NF-kappaB activation and NF-kappaB-related proinflammatory

Cheng-Yun Jin1, Dong-Oh Moon, Kyeong-Jun Lee

  • 1Department of Microbiology, College of Natural Sciences, Pusan National University, Busan 609-735, South Korea.

Pharmacological Research
|October 28, 2006
PubMed

Insights

Piceatannol (PIC) reduces key inflammatory molecules like nitric oxide (NO) and prostaglandin E(2) (PGE(2)) in brain cells. This natural compound shows potential for treating inflammatory brain conditions.

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • Proinflammatory mediators (PGE(2), NO, IL-1beta, IL-6, TNF-alpha) are crucial in brain injuries.
  • Anti-inflammatory responses involve downregulating these mediators post-injury.

Purpose of the Study:

  • To investigate the anti-inflammatory effects of piceatannol (PIC) on lipopolysaccharide (LPS)-stimulated BV2 microglia.
  • To determine PIC's impact on the production and expression of key inflammatory mediators and signaling pathways.

Main Methods:

  • BV2 microglia were stimulated with LPS.
  • The effects of varying concentrations of PIC on NO, PGE(2), and cytokine release were measured.
  • mRNA and protein levels of iNOS and COX-2 were assessed.
  • NF-kappaB p65 nuclear translocation was evaluated.

Main Results:

  • PIC significantly inhibited the release of NO, PGE(2), and proinflammatory cytokines in a dose-dependent manner.
  • PIC attenuated the expression of inducible NO synthase (iNOS) and cyclooxygenase (COX)-2 at mRNA and protein levels.
  • PIC prevented NF-kappaB p65 nuclear translocation, indicating suppression of this inflammatory pathway.

Conclusions:

  • Piceatannol exhibits significant anti-inflammatory properties in LPS-stimulated microglia.
  • PIC suppresses the transcription of proinflammatory cytokine genes via the NF-kappaB signaling pathway.
  • PIC's anti-inflammatory effects suggest potential therapeutic applications for inflammatory diseases and microglial activation.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of Bacterial Virulence01:28

Regulation of Bacterial Virulence

Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...